Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-28 @ 7:52 PM
Study NCT ID:
NCT04984733
Status:
RECRUITING
Last Update Posted:
2023-11-29
First Post:
2021-01-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide + Nivolumab in MGMT Methylated Oesophagogastric Cancer
Sponsor:
University of Southampton
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-09-28
Start Date Type:
ACTUAL
Primary Completion Date:
2024-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-07
Completion Date Type:
ESTIMATED
First Submit Date:
2021-01-13
First Submit QC Date:
None
Study First Post Date:
2021-07-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-11-28
Last Update Post Date:
2023-11-29
Last Update Post Date Type:
ACTUAL